An aptamer targets HBV core protein and suppresses HBV replication in HepG2.2.15 cells

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1423-1429

  Zhang, Zuowei ^a,b   Zhang, Jun ^a   Pei, Xiaoyu ^a   Zhang, Qi ^a,b   Lu, Bin ^a   Zhang, Xiaojiao ^a,b   Liu, Jie ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Aptamer; Hepatitis B virus; The core protein of hepatitis B virus

Indexed keywords

APTAMER; CORE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA; HEPATITIS B CORE ANTIGEN; PROTEIN BINDING; SINGLE STRANDED DNA;

AGAR GEL ELECTROPHORESIS; ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VIRUS CAPSID; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; CHEMISTRY; DRUG EFFECTS; GENE LIBRARY; GENETICS; HEPG2 CELL LINE; ISOLATION AND PURIFICATION; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEQUENCE ALIGNMENT;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CLONING, MOLECULAR; DNA, SINGLE-STRANDED; DNA, VIRAL; GENE LIBRARY; HEP G2 CELLS; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID; PROTEIN BINDING; SEQUENCE ALIGNMENT; VIRUS REPLICATION;

EID: 84907219435     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1908     Document Type: Article

References (34)

1. Ma X, Lin C and Zhen W: Cancer care in China: A general review. Biomed Imaging Interv J 4: e39, 2008.
2. Vigano M and Lampertico P: Antiviral drugs for HBV liver disease. Expert Opin Biol Ther 11: 285-300, 2011.
3. Yan H, Zhong G, Xu G, et al: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1: e00049, 2012.
4. Roseman AM, Berriman JA, Wynne SA, Butler PJ and Crowther RA: A structural model for maturation of the hepatitis B virus core. Proc Natl Acad Sci USA 102: 15821-15826, 2005.
5. Deres K, Schroder CH, Paessens A, et al: Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299: 893-896, 2003.
6. Kulbachinskiy AV: Methods for selection of aptamers to protein targets. Biochemistry (Moscow) 72: 1505-1518, 2007.
7. Sefah K, Shangguan D, Xiong X, O'Donoghue MB and Tan W: Development of DNA aptamers using Cell-SELEX. Nat Protoc 5: 1169-1185, 2010.
8. Chakravarthy U, Adamis AP, Cunningham ETJ, et al: Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113: 1508.e1501-1508.e1525, 2006.
9. Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR and Adamis AP: Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5: 123-132, 2006.
10. Ramalingam D, Duclair S, Datta SA, Ellington A, Rein A and Prasad VR: RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production. J Virol 85: 305-314, 2011.
11. Kikuchi K, Umehara T, Fukuda K, Kuno A, Hasegawa T and Nishikawa S: A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId. Nucleic Acids Res 33: 683-692, 2005.
12. Kikuchi K, Umehara T, Nishikawa F, Fukuda K, Hasegawa T and Nishikawa S: Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Biochem Biophys Res Commun 386: 118-123, 2009.
13. Chen F, Hu Y, Li D, Chen H and Zhang XL: CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2. PLoS One 4: e8142, 2009.
14. Neff CP, Zhou J, Remling L, et al: An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4+ T cell decline in humanized mice. Sci Transl Med 3: 66ra66, 2011.
15. Zhou J, Li H, Li S, Zaia J and Rossi JJ: Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther 16: 1481-1489, 2008.
16. Liu J, Yang Y, Hu B, et al: Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen. Virol Sin 25: 27-35, 2010.
17. Feng H, Beck J, Nassal M and Hu KH: A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication. PLoS One 6: e27862, 2011.
18. Ray P and White RR: Aptamers for targeted drug delivery. Pharmaceuticals 3: 1761-1778, 2010.
19. Jun-Bin S, Zhi C, Wei-Qin N and Jun F: A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. J Virol Methods 112: 45-52, 2003.
20. Zhang W, Ke W, Wu SS, et al: An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo. Peptides 30: 1816-1821, 2009.
21. Calvert J and Summers J: Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation. J Virol 68: 2084-2090, 1994.
22. Lu B, Wang J, Zhang J, et al: Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma. Acta Biochim Biophys Sin (Shanghai) 46: 128-135, 2014.
23. Devi U and Locarnini S: Hepatitis B antivirals and resistance. Curr Opin Virol 3: 495-500, 2013.
24. Ferapontova EE and Gothelf KV: Recent advances in electrochemical aptamer-based sensors. Curr Org Chem 15: 498-505, 2011.
25. Chu TC, Marks JW III, Lavery LA, et al: Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res 66: 5989-5992, 2006.
26. Wang JC, Dhason MS and Zlotnick A: Structural organization of pregenomic RNA and the carboxy-terminal domain of the capsid protein of hepatitis B virus. PLoS Pathog 8: e1002919, 2012.
27. Vanlandschoot P, Van Houtte F, Serruys B and Leroux-Roels G: The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate. J Gen Virol 86: 75-84, 2005.
28. Jammeh S, Tavner F, Watson R, Thomas HC and Karayiannis P: Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 89: 901-909, 2008.
29. Guo H, Jiang D, Zhou T, Cuconati A, Block TM and Guo JT: Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: An intermediate of covalently closed circular DNA formation. J Virol 81: 12472-12484, 2007.
30. Schmitz A, Schwarz A, Foss M, et al: Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket. PLoS Pathog 6: e1000741, 2010.
31. Masri HP and Cornelissen CN: Specific ligand binding attributable to individual epitopes of gonococcal transferrin binding protein A. Infect Immun 70: 732-740, 2002.
32. Yamada N and Tanoue E: Detection and partial characterization of dissolved glycoproteins in oceanic waters. Limnol Oceanogr 48: 1037-1048, 2003.
33. Tomai E, Butz K, Lohrey C, von Weizsacker F, Zentgraf H and Hoppe-Seyler F: Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes. J Biol Chem 281: 21345-21352, 2006.
34. Butz K, Denk C, Fitscher B, et al: Peptide aptamers targeting the hepatitis B virus core protein: A new class of molecules with antiviral activity. Oncogene 20: 6579-6586, 2001.